[1] Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass[J]. Ann Thorac Surg, 1993, 55(2): 552-9. [2] Wan S, LeClerc JL, Vincent JL. Inflammatory respopce to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies[J]. Chest, 1997, 112(3): 676-88. [3] Tobin MJ. Respiratory monitoring[J]. JAMA, 1990, 246(2): 244-51. [4] George A, Peter LCS, Chandana PR, et al. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass[J]. Ann Thorac Surg, 1999, 68(3): 1107-15. [5] Heering P, Morgera S, Schmitz FJ, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration[J]. Intensive Care Med, 1997, 23(3):288-96. [6] Silvester W. Mediator removal with CRRT: complement and cytokines[J]. Am J Kidney Dis, 1997, 30(5 Suppl 4): S38-43. [7] Bouman CS, van Olden RW, Stoutenbeek CP. Cytokine filtration and adsorption during pre- and post-dilution hemofiltration in four different membranes[J]. Blood Purif, 1998, 16(5): 261-8. [8] de Vriese AS, Colardyn FA, Philippe JJ,et al. Cytokine removal during continuous hemofiltration in septic patients [J]. J Am Soc Nephrol, 1999, 10(4): 846-53. [9] Fujimori A, Naito H, Miyazaki T. Adsorption of complement, cytokines, and proteins by different dialysis membrane materials: evaluation by confocal laser scanning fluorescence microscopy [J].Artif Organs, 1998, 22(12): 1014-7. [10] Rogiers P, Zhang H, Pauwels D, et al. Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock[J]. Crit Care Med, 2003, 31(4): 1219-25. |